Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2016 by Cancer Research UK
Sponsor:
Information provided by (Responsible Party):
Cancer Research UK
ClinicalTrials.gov Identifier:
NCT01390571
First received: July 7, 2011
Last updated: April 13, 2016
Last verified: April 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: May 2017 (Final data collection date for primary outcome measure)